That growth is being driven largely by enterprise demand. Companies are integrating Anthropic’s models into internal workflows and customer-facing tools via APIs, while a smaller share of revenue comes from subscriptions to premium chatbot features, according to The Information.
The momentum is also showing up in customer spend. Anthropic now counts more than 1,000 enterprise clients paying over $1 million annually, a figure that has more than doubled in recent months, signaling a shift from experimentation to full-scale deployment.
At the same time, the surge is tightening the competitive race. Anthropic’s trajectory is closing the gap with larger competitors like OpenAI, which generated an estimated $25 billion annualized revenue earlier this year. This underscores how enterprise AI spending is expanding quickly across multiple providers rather than consolidating around one.
The expansion comes even as Anthropic faces regulatory scrutiny in the United States, as PYMNTS previously reported. The company is contesting a federal designation that labeled it a potential supply chain risk, a move it has warned could cost billions in lost revenue. The dispute has introduced uncertainty among some enterprise customers, with more than 100 reportedly raising concerns about continuing their relationships with Anthropic, according to Bloomberg.
Enterprise Adoption Drives Growth
Anthropic’s growth reflects broader enterprise adoption of AI tools. Companies are moving beyond early chatbot experiments and deploying models across functions such as software development, customer support and internal data operations. The rise in customers spending more than $1 million annually suggests that AI usage is shifting from limited pilots to larger, production-level deployments.
That demand is also shaping how AI companies structure their offerings. Rather than focusing solely on consumer-facing chat interfaces, Anthropic has leaned into developer tools and enterprise integrations, where usage scales with business activity.
The company’s growth strategy is also extending beyond its core model business. Anthropic is reportedly planning a $200 million investment into a new private equity-backed venture aimed at distributing AI tools across portfolio companies, as covered by PYMNTS.
At the same time, it is expanding into industry-specific applications. Anthropic has agreed to acquire biotech startup Coefficient Bio for roughly $400 million, targeting the use of AI in drug discovery and clinical workflows, according to PYMNTS.
For all PYMNTS AI coverage, subscribe to the daily AI Newsletter.